U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination
    • Showing Current items.

    MYB MYB proto-oncogene, transcription factor [ Homo sapiens (human) ]

    Gene ID: 4602, updated on 27-Nov-2024

    GeneRIFs: Gene References Into Functions

    GeneRIFPubMed TitleDate
    Proto-oncogene c-Myb potentiates cisplatin resistance of ovarian cancer cells by downregulating lncRNA NKILA and modulating cancer stemness and LIN28A-let7 axis.

    Proto-oncogene c-Myb potentiates cisplatin resistance of ovarian cancer cells by downregulating lncRNA NKILA and modulating cancer stemness and LIN28A-let7 axis.
    Zhang XY, Zhu BC, He M, Dong SS., Free PMC Article

    07/30/2024
    hnRNPA0 promotes MYB expression by interacting with enhancer lncRNA MY34UE-AS in human leukemia cells.

    hnRNPA0 promotes MYB expression by interacting with enhancer lncRNA MY34UE-AS in human leukemia cells.
    Liu C, Wang Y, Shi M, Tao X, Man D, Zhang J, Han B.

    07/12/2024
    Adenoid cystic carcinoma of the Bartholin's gland is underpinned by MYB- and MYBL1- rearrangements.

    Adenoid cystic carcinoma of the Bartholin's gland is underpinned by MYB- and MYBL1- rearrangements.
    Feinberg J, Da Cruz Paula A, da Silva EM, Pareja F, Patel J, Zhu Y, Selenica P, Leitao MM Jr, Abu-Rustum NR, Reis-Filho JS, Joehlin-Price A, Weigelt B.,

    06/28/2024
    lncRNA SNHG4 inhibits ferroptosis by orchestrating miR-150-5p/c-Myb axis in colorectal cancer.

    lncRNA SNHG4 inhibits ferroptosis by orchestrating miR-150-5p/c-Myb axis in colorectal cancer.
    Li SQ, Lv F, Xu WT, Yin YX, Wei HT, Li KZ, Hu BL.

    06/3/2024
    From modulation of cellular plasticity to potentiation of therapeutic resistance: new and emerging roles of MYB transcription factors in human malignancies.

    From modulation of cellular plasticity to potentiation of therapeutic resistance: new and emerging roles of MYB transcription factors in human malignancies.
    Anand S, Vikramdeo KS, Sudan SK, Sharma A, Acharya S, Khan MA, Singh S, Singh AP., Free PMC Article

    04/17/2024
    MYB alternative promoter activity is increased in adenoid cystic carcinoma metastases and is associated with a specific gene expression signature.

    MYB alternative promoter activity is increased in adenoid cystic carcinoma metastases and is associated with a specific gene expression signature.
    Huang J, Fehr A, Jäwert F, Nilsson JA, Morris LGT, Stenman G, Andersson MK.

    04/11/2024
    MYB/LINC00092 regulatory axis promotes the progression of papillary thyroid carcinoma.

    MYB/LINC00092 regulatory axis promotes the progression of papillary thyroid carcinoma.
    Cheng L, Deng X, Le Y.

    03/22/2024
    The mitotic checkpoint kinase BUB1 is a direct and actionable target of MYB in adenoid cystic carcinoma.

    The mitotic checkpoint kinase BUB1 is a direct and actionable target of MYB in adenoid cystic carcinoma.
    Cicirò Y, Ragusa D, Nevado PT, Lattanzio R, Sala G, DesRochers T, Millard M, Andersson MK, Stenman G, Sala A.

    02/5/2024
    Solid-Basaloid Adenoid Cystic Carcinoma of the Breast: An Aggressive Subtype Enriched for Notch Pathway and Chromatin Modifier Mutations With MYB Overexpression.

    Solid-Basaloid Adenoid Cystic Carcinoma of the Breast: An Aggressive Subtype Enriched for Notch Pathway and Chromatin Modifier Mutations With MYB Overexpression.
    Shamir ER, Bean GR, Schwartz CJ, Vohra P, Wang A, Allard GM, Wolsky RJ, Garcia JJ, Chen YY, Krings G.

    01/3/2024
    Reversal of MYB-dependent suppression of MAFB expression overrides leukaemia phenotype in MLL-rearranged AML.

    Reversal of MYB-dependent suppression of MAFB expression overrides leukaemia phenotype in MLL-rearranged AML.
    Negri A, Ward C, Bucci A, D'Angelo G, Cauchy P, Radesco A, Ventura AB, Walton DS, Clarke M, Mandriani B, Pappagallo SA, Mondelli P, Liao K, Gargano G, Zaccaria GM, Viggiano L, Lasorsa FM, Ahmed A, Di Molfetta D, Fiermonte G, Cives M, Guarini A, Vegliante MC, Ciavarella S, Frampton J, Volpe G., Free PMC Article

    12/1/2023
    LncRNA PART1 Regulates Ovarian Carcinoma Development via the miR-150-5p/MYB Axis.

    LncRNA PART1 Regulates Ovarian Carcinoma Development via the miR-150-5p/MYB Axis.
    Wang J, Han Y, Zhang T, Li J, Xu B.

    11/8/2023
    MYB regulates the SUMO protease SENP1 and its novel interaction partner UXT, modulating MYB target genes and the SUMO landscape.

    MYB regulates the SUMO protease SENP1 and its novel interaction partner UXT, modulating MYB target genes and the SUMO landscape.
    Lemma RB, Ledsaak M, Fuglerud BM, Rodríguez-Castañeda F, Eskeland R, Gabrielsen OS., Free PMC Article

    10/4/2023
    rs71327024 Associated with COVID-19 Hospitalization Reduces CXCR6 Promoter Activity in Human CD4[+] T Cells via Disruption of c-Myb Binding.

    rs71327024 Associated with COVID-19 Hospitalization Reduces CXCR6 Promoter Activity in Human CD4(+) T Cells via Disruption of c-Myb Binding.
    Uvarova AN, Stasevich EM, Ustiugova AS, Mitkin NA, Zheremyan EA, Sheetikov SA, Zornikova KV, Bogolyubova AV, Rubtsov MA, Kulakovskiy IV, Kuprash DV, Korneev KV, Schwartz AM., Free PMC Article

    09/30/2023
    Gallbladder cancer-associated genetic variants rs1003349 and rs1004030 regulate MMP14 expression by altering SOX10- and MYB-binding sites.

    Gallbladder cancer-associated genetic variants rs1003349 and rs1004030 regulate MMP14 expression by altering SOX10- and MYB-binding sites.
    J V, Palo A, Besra K, Dixit M.

    07/12/2023
    Pediatric-type diffuse low-grade glioma with MYB/MYBL1 alteration: report of 2 cases.

    Pediatric-type diffuse low-grade glioma with MYB/MYBL1 alteration: report of 2 cases.
    Kalelioglu T, Rama B, Cho BB, Lopes BM, Patel SH., Free PMC Article

    03/23/2023
    C/EBPbeta cooperates with MYB to maintain the oncogenic program of AML cells.

    C/EBPβ cooperates with MYB to maintain the oncogenic program of AML cells.
    Klempnauer KH., Free PMC Article

    03/20/2023
    Biphasic transcriptional and posttranscriptional regulation of MYB by androgen signaling mediates its growth control in prostate cancer.

    Biphasic transcriptional and posttranscriptional regulation of MYB by androgen signaling mediates its growth control in prostate cancer.
    Acharya S, Anand S, Khan MA, Zubair H, Srivastava SK, Singh S, Singh AP., Free PMC Article

    02/4/2023
    MYB and ELF3 differentially modulate labor-inducing gene expression in myometrial cells.

    MYB and ELF3 differentially modulate labor-inducing gene expression in myometrial cells.
    Shchuka VM, Khader N, Dorogin A, Shynlova O, Mitchell JA., Free PMC Article

    01/11/2023
    Recurrent noncoding somatic and germline WT1 variants converge to disrupt MYB binding in acute promyelocytic leukemia.

    Recurrent noncoding somatic and germline WT1 variants converge to disrupt MYB binding in acute promyelocytic leukemia.
    Song H, Liu Y, Tan Y, Zhang Y, Jin W, Chen L, Wu S, Yan J, Li J, Chen Z, Chen S, Wang K., Free PMC Article

    09/24/2022
    LncRNA BC200/miR-150-5p/MYB positive feedback loop promotes the malignant proliferation of myelodysplastic syndrome.

    LncRNA BC200/miR-150-5p/MYB positive feedback loop promotes the malignant proliferation of myelodysplastic syndrome.
    Liu Z, Wang P, Yuan S, Wang Y, Cao P, Wen F, Li H, Zhu L, Liang L, Wang Z, Hu B, Zheng F, Liu J, Xiao X, Zhang J., Free PMC Article

    04/16/2022
    c-Myb facilitates immune escape of esophageal adenocarcinoma cells through the miR-145-5p/SPOP/PD-L1 axis.

    c-Myb facilitates immune escape of esophageal adenocarcinoma cells through the miR-145-5p/SPOP/PD-L1 axis.
    Zhang L, Wang X, Li Y, Han J, Gao X, Li S, Wang F., Free PMC Article

    02/12/2022
    Mitochondrial genome copy number measured by DNA sequencing in human blood is strongly associated with metabolic traits via cell-type composition differences.

    Mitochondrial genome copy number measured by DNA sequencing in human blood is strongly associated with metabolic traits via cell-type composition differences.
    Ganel L, Chen L, Christ R, Vangipurapu J, Young E, Das I, Kanchi K, Larson D, Regier A, Abel H, Kang CJ, Scott A, Havulinna A, Chiang CWK, Service S, Freimer N, Palotie A, Ripatti S, Kuusisto J, Boehnke M, Laakso M, Locke A, Stitziel NO, Hall IM., Free PMC Article

    02/5/2022
    circFAT1(e2) Inhibits Cell Apoptosis and Facilitates Progression in Vascular Smooth Muscle Cells through miR-298/MYB Axis.

    circFAT1(e2) Inhibits Cell Apoptosis and Facilitates Progression in Vascular Smooth Muscle Cells through miR-298/MYB Axis.
    Shi Z, Ye S, Xiang Y, Wu D, Xu J, Yu J, Zeng C, Jiang J, Hu W., Free PMC Article

    02/5/2022
    MYB rearrangements and over-expression in T-cell acute lymphoblastic leukemia.

    MYB rearrangements and over-expression in T-cell acute lymphoblastic leukemia.
    Bardelli V, Arniani S, Pierini V, Pierini T, Di Giacomo D, Gorello P, Moretti M, Pellanera F, Elia L, Vitale A, Storlazzi CT, Tolomeo D, Mastrodicasa E, Caniglia M, Chiaretti S, Ruggeri L, Roti G, Schwab C, Harrison CJ, Almeida A, Pieters T, Van Vlierberghe P, Mecucci C, La Starza R.

    02/5/2022
    Proteasome inhibitors suppress MYB oncogenic activity in a p300-dependent manner.

    Proteasome inhibitors suppress MYB oncogenic activity in a p300-dependent manner.
    Yusenko MV, Biyanee A, Andersson MK, Radetzki S, von Kries JP, Stenman G, Klempnauer KH.

    01/8/2022
    firstprevious page of 11 nextlast